Taken together, these data indicate that endothelial cells of SSc patients may trigger fibrosis initiation by inducing a CTGF/TGF-β-dependent fibroblast mesenchymal-to-mesenchymal transition, that is, an increase of their mesenchymal properties. Here, CCN2 is linked to systemic sclerosis.